Merchant, Fahar

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Merchant, Fahar's trades of Medicenna Therapeutics Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
374.60
Quantity 25,867
Value CA$1,778,030
Transaction date
Purchase
Price
253.34
Quantity 95,568 -7.4%
Value CA$1,243,520
Transaction date
Purchase
Price
412.90
Quantity 19,473 -27.7%
Value CA$2,020,753
Transaction date
Purchase
Price
1.12
Quantity 15,000 +48.4%
Value CA$16,800
Transaction date
Purchase
Price
0.92
Quantity 30,000 +0.6%
Value CA$27,600
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-05-28
B Purchase
25,867
374.60
CA$1,778,030 		25,867 374.60 CA$1,778,030
2026-06-02 2026-05-28
B Purchase
95,568 -7.4%
253.34
CA$1,243,520 		95,568 -7.4% 253.34 CA$1,243,520
2025-12-15 2025-12-15
B Purchase
19,473 -27.7%
412.90
CA$2,020,753 		19,473 -27.7% 412.90 CA$2,020,753
2025-12-12 2025-12-12
B Purchase
15,000 +48.4%
1.12
CA$16,800 		15,000 +48.4% 1.12 CA$16,800
2023-02-22 2023-02-21
B Purchase
30,000 +0.6%
0.92
CA$27,600 		30,000 +0.6% 0.92 CA$27,600